Skip to content

13F-HR filed by TCG Crossover Management, LLC

TCG Crossover Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:24:13 UTC, with 57 holding rows worth $3,539,842,492.

Accession
0001214659-26-014306
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 57 entries on the cover page, a total value of $3,539,842,492 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,539,842,492 with VALUE read as dollars as filed, 13F file number 028-22283. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ABIVAX SA-00370M103SPONSORED ADS3,663,038$362,714,023dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK3,670,206$260,180,903dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM6,243,812$181,694,929dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW1,900,582$169,208,815dollars as filed
TANGO THERAPEUTICS INC87583X109COM6,773,043$168,987,423dollars as filed
ZAI LAB LTD ADR98887Q104ADR6,229,081$164,073,994dollars as filed
IMMUNOVANT INC45258J102COM4,457,988$150,590,835dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM1,676,624$147,626,743dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK4,549,587$145,586,784dollars as filed
KODIAK SCIENCES INC50015M109COM1,445,538$137,037,002dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK5,673,078$108,242,328dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*2,895,304$102,609,574dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM1,118,967$95,649,299dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock11,020,968$91,804,663dollars as filed
DISC MEDICINE INC COM254604101Stock1,341,862$87,838,287dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share4,116,452$82,082,053dollars as filed
COGENT BIOSCIENCES INC19240Q201COM2,500,003$80,050,096dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK3,475,980$76,019,683dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock4,615,144$74,349,970dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock3,783,529$68,292,698dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK10,165,357$63,838,442dollars as filed
SAVARA INC805111101COM12,362,205$63,788,978dollars as filed
XENCOR INC98401F105COMMON STOCK2,055,938$51,295,653dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK3,017,120$46,252,450dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM3,781,532$45,113,677dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock650,000$38,103,000dollars as filed
ENTERA BIO LTDM40527109SHS12,254,901$35,661,762dollars as filed
JANUX THERAPEUTICS INC47103J105COM1,789,617$30,924,582dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK388,164$30,513,572dollars as filed
CENTURY THERAPEUTICS INC15673T100COM17,754,430$30,360,075dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share2,196,138$30,152,975dollars as filed
PHARVARIS NVN69605108COMMON STOCK947,544$30,056,096dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK765,050$29,362,619dollars as filed
EDITAS MEDICINE INC28106W103COM11,111,111$28,555,555dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK1,204,891$28,061,911dollars as filed
Inflarx NvN44821101COM14,500,000$26,100,000dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK7,915,567$21,767,809dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS1,820,831$20,211,224dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS1,819,035$19,882,053dollars as filed
ALECTOR INC014442107COMMON STOCK10,000,000$18,500,000dollars as filed
BIOHAVEN LTDG1110E107COM1,262,423$16,853,347dollars as filed
MONOPAR THERAPEUTICS INC61023L207COMMON STOCK202,242$16,112,620dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK11,390,175$13,896,014dollars as filed
ENTRADA THERAPEUTICS INC COM29384C108Stock1,060,230$6,732,461dollars as filed
CULLINAN THERAPEUTICS INC230031106COM406,786$6,244,165dollars as filed
AGENUS INC00847G804COM NEW603,892$5,996,648dollars as filed
OCULAR THERAPEUTIX INC67576A100COM720,323$5,524,877dollars as filed
ARVINAS INC04335A105COM707,098$5,469,403dollars as filed
KORRO BIO INC500946108COMMON STOCK416,301$4,125,543dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS300,000$3,600,000dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK2,465,436$3,426,956dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK133,457$2,598,408dollars as filed
JATT II ACQUISITION CORPG50765109ORD SHS200,000$2,249,000dollars as filed
LeonaBio Inc04746L203COM464,398$1,657,901dollars as filed
JATT III ACQUISITION CORPG5080G109COM100,000$1,102,000dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM2,682,696$805,882dollars as filed
EIKON THERAPEUTICS INC282564103COMMON STOCK37,902$304,732dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-26-014306this filing2026-11-16